A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients.

A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients.

Item
http://www.wikidata.org/entity/Q36388027
Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis.Optimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practice.Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states.Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malariaItraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections.Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infection.Importance of characterizing determinants of variability in exposure: application to dasatinib in subjects with chronic myeloid leukemia.Population in vitro-in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole.Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?
P2860

A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients.

Item
http://www.wikidata.org/entity/Q36388027
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
A d-optimal designed populatio ...... dult cystic fibrosis patients.
@ast
A d-optimal designed populatio ...... dult cystic fibrosis patients.
@en
type
label
A d-optimal designed populatio ...... dult cystic fibrosis patients.
@ast
A d-optimal designed populatio ...... dult cystic fibrosis patients.
@en
prefLabel
A d-optimal designed populatio ...... dult cystic fibrosis patients.
@ast
A d-optimal designed populatio ...... dult cystic fibrosis patients.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
A d-optimal designed populatio ...... dult cystic fibrosis patients.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2125.2006.02778.X
P407
P433
P478
P50
P577
P5875
P698
P921
P932